EMGALITY: payments to doctors
Payments that named EMGALITY as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $13.3M
- Providers
- 66,312
- Transactions
- 316,052
- Average per transaction
- $42
The per-transaction average — $42 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 66,312 providers the average total is $200, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Lilly USA, LLC | $13,159,909 | 99.1% |
| Eli Lilly | $97,598 | 0.7% |
| Eli Lilly Export S.A. Puerto Rico Branch | $27,736 | 0.2% |